The tumor ablation market can be segmented based on the type of technology used, which includes Microwave and High-Intensity Focused Ultrasound (HIFU). Microwave tumor ablation technology has gained popularity due to its ability to generate high heat within the tumor tissue, leading to effective destruction of cancer cells. On the other hand, HIFU technology uses focused ultrasound waves to heat and destroy the tumor tissues. The market share for microwave technology is expected to be higher than HIFU, driven by its widespread adoption and proven efficacy in tumor ablation procedures.
Treatment:
In terms of treatment, the tumor ablation market can be categorized into Laparoscopic Ablation and Percutaneous Ablation. Laparoscopic ablation involves the use of a laparoscope to visualize and ablate the tumor, while Percutaneous ablation is a minimally invasive procedure that involves inserting a probe through the skin to ablate the tumor. The preference for percutaneous ablation is expected to be higher due to its less invasive nature, shorter recovery time, and reduced risk of complications compared to laparoscopic ablation.
Application:
The tumor ablation market can also be segmented based on the application, which includes Liver Cancer and Lung Cancer. Liver cancer accounts for a significant share of the tumor ablation market, driven by the increasing incidence of liver cancer globally. Ablation procedures for liver cancer offer a minimally invasive treatment option for patients who are not suitable for surgery. On the other hand, lung cancer ablation procedures are gaining traction due to their ability to target and destroy tumors in the lungs, especially in cases where surgical resection is not feasible. The market share for liver cancer ablation procedures is expected to be higher than lung cancer ablation, reflecting the higher prevalence of liver cancer worldwide.